Altogether these studies suggest that the dual β1/β3-AR modulation, already demonstrated in previous studies for heart failure and myocardial infarction with Nebivolol49, could be extended to patients with β1-aabs-induced DCM. The gene discussed is ADRB3; the disease is myocardial infarction.